Technologies by A. Fatih Sarioglu
Saliva-Based Multiplexed Assay with 25x Higher Sensitivity to SARS-CoV-2 and Influenza A and B

Low sensitivity of current lateral flow assays results in high rates of false negatives

9149
Paper-Based Multi-Well Depletion Enzyme-Linked Immunosorbent Assay (ELISA) Enables Point-of-Care (POC) Testing
ELISA tests require centralized laboratories staffed with trained personnel
9124
Capillary Flow Control in Lateral Flow Assays (LFAs) via Delaminating Timers
Advancing the state-of-the-art in LFAs and point-of-care diagnostics
8462, 8634
Cluster-Wells: Isolating Aggressive Tumor Cell Clusters for Improved Cancer Diagnosis and Treatment
A high-throughput polymer chip that provides an efficient, scalable method for analyzing circulating tumor cell clusters
8203
Integrating Electrical Sensors into Soft-Lithography Microfluidic Devices
A streamlined fabrication process for creating a parallel electrode arrangement
7769
Microfluidic CODES with Innovative Machine-Learning Analysis
A convolutional neural network-based algorithm that augments multiplexed Coulter sensor networks for real-time cell/particle analysis
7107, 8032
Utilizing Impedance Spectroscopy for Advanced Characterization of Particles
A cell analysis technique for microfluidic devices that simultaneously measures the spatial and dielectric properties of particles
8049
All-Electronic Immunophenotyping Device for Point-of-Care Testing
A convenient microarray system that allows for digital immunoanalysis
8045, 8047
Scalable Microfluidic Device with Multiple Constriction Channels for High-Throughput Mechanophenotyping
A straightforward lab-on-a-chip system with parallel channels to minimize idle time
8031
Measuring Surface Antigen Expression via Microflow Cytometry
An inexpensive microfluidic device that utilizes magnetophoresis to determine the density of antigens on cell surfaces
7913, 8048
3D Printed Device for Tumor Cell Diagnostics
This technology is a portable, disposable, 3D-printed microfluidic platform that can isolate viable circulating tumor cells (CTCs) from blood samples
7346